Breast-mesh lawsuits allege GalaFLEX mesh used as an "internal bra" caused infection, chronic pain, implant loss and repeat surgery. An "internal bra" is surgical mesh placed inside the breast to support an implant or lifted tissue.
The first complaints were filed April 28, 2026 in Rhode Island Superior Court against Becton Dickinson, Davol, C.R. Bard, Tepha and Galatea, according to AboutLawsuits.com's detailed report on the first GalaFLEX cases. For readers, the practical questions are what was implanted, what harm followed and what the records show.
Official resources:
- Read the official guidance from NIH — Use this primary source to verify the official guidance.
- Read the official guidance from FDA — Use this primary source to verify the official guidance.
Table of Contents
- Why is breast use legally different?
- What injuries do the lawsuits blame on the mesh?
- What do complication studies show?
- What should you do if you had mesh with implants?
Why is breast use legally different?
An internal bra is meant to hold shape, reduce sag and support weight after augmentation, lift or reconstruction. Surgeons have used mesh for this support even though breast procedures raise distinct safety questions.
No surgical mesh is cleared or approved for use with breast implants or breast reconstruction, according to the U.S. Food and Drug Administration's breast implant surgery page. The agency therefore has not reviewed benefits and risks for those breast uses.
What injuries do the lawsuits blame on the mesh?
According to AboutLawsuits.com's November 2026 lawsuit update, plaintiffs allege infection, chronic pain, seroma and capsular contracture. The same update says they also allege mesh migration or failure, implant loss or deformity and revision or removal surgery.
📨 Get Free Mass Tort Guides Alerts
Free · No spam · Unsubscribe anytime
In plain terms, seroma means fluid collecting around the surgical site. Capsular contracture means scar tissue tightens and hardens around the implant. Migration or failure means the mesh moves, breaks down or stops supporting the breast.
What do complication studies show?
A 2025 systematic review in Plastic and Reconstructive Surgery–Global Open pooled infection or abscess at 3.61% and seroma at 5.04%, according to the published systematic review. In that review, implant removal commonly followed infection or contracture. That review drew on heterogeneous observational studies with high statistical heterogeneity, so averages do not prove individual causation or a uniform GalaFLEX-specific rate.
That limit matters because study patients, techniques, mesh types and follow-up differed. A pooled average can describe published reports without predicting one person's outcome. GalaFLEX-specific risk cannot be read directly from the combined figure.
What should you do if you had mesh with implants?
Start with records before deciding about legal or medical next steps. operative notes usually identify whether mesh was used and which brand was placed.
Report implant or mesh problems through FDA MedWatch. Bring the operative report to every follow-up visit so each new clinician can see the exact mesh brand.
- Get the operative report, implant details and any mesh brand or lot information.
- Ask the surgeon what benefit mesh was expected to add and what mesh-specific risks were discussed.
- Track fever, swelling, fluid collection, worsening pain, hardening, shifting shape or wound problems, and seek prompt care if they appear.
You Might Also Like
- Gabapentin Lawsuit Filings Rise Over Dementia Injury Claims
- Eaton Fire Lawsuit Against SCE: What Negligence Claims Allege
- Asbestos Lawsuit Trust Funds: How Liability Claims Get Paid